Jul 2026 (Q2 FY27) — Sep 3, 2026
DocuSign Q2 FY27 — Strong IAM Adoption and Raised ARR Guidance
Read the full callDocuSign earnings: last reported Thu, 3 Sep 2026, for the quarter ended Jul 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 876 | +9.4% YoY | Quarterly, as filed | Quarter to Jul 2026 | Revenue from operations as filed. |
| Operating margin | 13.4 | +5.3 pts YoY | Operating profit / revenue | Quarter to Jul 2026 | For the quarter; a change is in percentage points. |
| Net profit | 77.7 | +23.4% YoY | Quarterly, as filed | Quarter to Jul 2026 | Profit after tax as filed. |
Guidance
59 of 61 judged targets kept · 27 open · verdicts reflect calls analysed to Apr 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Discontinuation of billings as a reported metric | no longer report billings in fiscal 2027; Q4 fiscal 2026 the last quarter reported | Oct 2025 | To the question regarding on billings, we didn't guide to billings, and I just want to remind folks, billings can be quite volatile on a quarter-to-quarter basis just due to timing. | Achieved |
| Billings | $741 million to $751 million (5% year-over-year growth at the midpoint) | Jan 2025 | I think our billings grew 4% year-over-year in Q1 last year and the full year grew 9.5%. | Missed |
| Full-year non-GAAP operating margin | 30.0% to 30.5% | Jan 2026 | We expect non-GAAP operating margin to reach 29.7% to 30.2% for Q2 and 30.5% to 31.0% for fiscal 2027, an increase of 0.5% at the midpoint versus prior guidance. | Revised Up |
2 of DOCUSIGN, INC.'s 88 targets were missed. See which ones, and which are quietly gone. The 3 above are the free sample; 85 more targets are in the full ledger.
Claimed
Qualified
Price
1Y: $67.93 on 17 Oct 2025 → $76.66. High $77.52 (15 Oct 2026), low $41.75 (23 Feb 2026).
Overview
Guidance
59 of 61 judged targets kept · 27 open · verdicts reflect calls analysed to Apr 2026.
| Target | Original wording | Said | Latest call | Verdict |
|---|---|---|---|---|
| Discontinuation of billings as a reported metric | no longer report billings in fiscal 2027; Q4 fiscal 2026 the last quarter reported | Oct 2025 | To the question regarding on billings, we didn't guide to billings, and I just want to remind folks, billings can be quite volatile on a quarter-to-quarter basis just due to timing. | Achieved |
| Billings | $741 million to $751 million (5% year-over-year growth at the midpoint) | Jan 2025 | I think our billings grew 4% year-over-year in Q1 last year and the full year grew 9.5%. | Missed |
| Full-year non-GAAP operating margin | 30.0% to 30.5% | Jan 2026 | We expect non-GAAP operating margin to reach 29.7% to 30.2% for Q2 and 30.5% to 31.0% for fiscal 2027, an increase of 0.5% at the midpoint versus prior guidance. | Revised Up |
Claimed
Qualified
The full ledger
A free account opens 5 company ledgers a month. All 88 tracked commitments, with each call’s wording and source.
Call summaries
DocuSign Q2 FY27 — Strong IAM Adoption and Raised ARR Guidance
Read the full callDocuSign Q1 FY27 — IAM reaches 12.6% of ARR as buybacks hit a record $318M
Read the full callDocuSign Q4 FY26 — IAM Drives ARR Growth and Profitability
Read the full callEvery analysed call
Financials
Net profit, year on year: +23% (quarter to jul 2026 against jul 2025).
| Line item | Oct 2024 | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 755 | 776 | 764 | 801 | 818 | 837 | 830 | 876 |
| Operating profit | 59 | 60 | 60 | 65 | 85 | 88 | 111 | 118 |
| Operating margin | 7.8% | 7.8% | 7.9% | 8.2% | 10.4% | 10.5% | 13.4% | 13.4% |
| Other income | 13 | 8 | 14 | 12 | 11 | 14 | 7 | 8 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 72 | 68 | 74 | 76 | 96 | 102 | 118 | 125 |
| Tax rate | 12.8% | −23.0% | 2.3% | 17.6% | 12.4% | 11.1% | 33.6% | 37.8% |
| Net profit | 62 | 83 | 72 | 63 | 84 | 90 | 78 | 78 |
| EPS ($ per share) | 0.31 | — | 0.35 | 0.31 | 0.41 | — | 0.40 | 0.41 |
| Line item | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -929 | -1,137 | -1,380 | -1,438 | -1,599 | -1,670 | -1,287 | -1,856 |
| Total liabilities | 1,001 | 1,345 | 2,007 | 2,266 | 2,395 | 1,842 | 2,010 | 2,312 |
| Fixed assets | 76 | 128 | 165 | 185 | 200 | 245 | 299 | 362 |
| Total assets | 1,615 | 1,891 | 2,337 | 2,541 | 3,013 | 2,971 | 4,013 | 4,230 |
| Line item | Jan 2019 | Jan 2020 | Jan 2021 | Jan 2022 | Jan 2023 | Jan 2024 | Jan 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 76 | 116 | 297 | 506 | 507 | 980 | 1,017 | 1,165 |
| Cash from investing | -664 | -321 | 81 | -163 | -191 | 45 | -313 | -127 |
| Cash from financing | 853 | -70 | -59 | -395 | -98 | -946 | -839 | -1,100 |
| Net cash flow | 261 | -277 | 325 | -57 | 214 | 78 | -142 | -41 |
| Capital expenditure | -30 | -72 | -82 | -61 | -78 | -92 | -97 | -106 |
| Free cash flow | 46 | 44 | 215 | 445 | 429 | 887 | 920 | 1,059 |
| Segment | Q2 FY2025 | Q3 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | Q1 FY2027 | Q2 FY2027 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Reportable | — | — | 100% | 100% | 100% | 100% | 100% | 100% | +9.4% |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
| KPI | Jan 2026 Q4 FY26 | Apr 2026 Q1 FY27 | Jul 2026 Q2 FY27 | Change vs prior quarter |
|---|---|---|---|---|
| Customers above an annual spend threshold | 1,205We ended the quarter with 1,205 customers spending over $300,000 annually, a 7% increase year-over-year.Source: earnings call transcript | 1,258We also saw the number of customers spending over $300,000 in ACV grow to 1,258, accelerating to 12% year-over-year growth the first time in 3 years that we have seen double-digit growth in this metric.Source: earnings call transcript | <1,300We also saw the number of customers spending over $300,000 in ACV grow 14% year-over-year to nearly 1,300, the second quarter in a row of double-digit growth.Source: earnings call transcript | — |
| Employees | 7,044We ended fiscal 2026 with 7,044 employees, up modestly from 6,838 a year ago, as we continue to invest deliberately in roles focused on growing the IAM platform.Source: earnings call transcript | 6,991We ended Q1 with 6,991 employees, down sequentially from Q4.Source: earnings call transcript | 7,137We ended Q2 with 7,137 employees, up 3% year-over-year.Source: earnings call transcript | +2.1% |
| Net revenue retention rate Direct | — | 102%+Dollar net retention or DNR with our direct customers was over 102%, a greater than 1 percentage point improvement versus Q1 of fiscal 2026.Source: earnings call transcript | 103%Dollar net retention, or DNR, from our Direct customers was 103% on a rounded basis, up modestly from last quarter and the prior year.Source: earnings call transcript | — |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Q2 FY2027 · share of revenue
As DOCU cuts its regions in its filings; they can nest, so they need not add to 100%.
162 filings between Nov 28, 2025 and Oct 1, 2026.
Purchases
None
No insider bought shares.
Sales
$23.09M
74 sales by 10 insiders
96% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Also filed: 2 gifts.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Thygesen Allan C. | — | $6.11M | Oct 1, 2026 |
| GRAYSON BLAKE JEFFREY | — | $5.77M | Sep 8, 2026 |
| Chatwani Robert | — | $3.64M | Sep 17, 2026 |
| Solvik Peter | — | $3.00M | Sep 10, 2026 |
| Shaughnessy James P | — | $2.74M | Oct 1, 2026 |
| Hansen Paula | — | $1.18M | Oct 1, 2026 |
| Wilderotter Mary Agnes | — | $290.6K | Oct 1, 2026 |
| Marrs Anna | — | $156.4K | Sep 14, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | Thygesen Allan C. President and CEO | Sale 10b5-1 plan | 7,475 | $512.3K |
| Oct 1, 2026 | Thygesen Allan C. President and CEO | Sale 10b5-1 plan | 13,598 | $944.4K |
| Oct 1, 2026 | Shaughnessy James P Chief Legal Officer | Sale 10b5-1 plan | 11,600 | $797.7K |
| Oct 1, 2026 | Thygesen Allan C. President and CEO | Sale 10b5-1 plan | 5,177 | $362.3K |
| Oct 1, 2026 | Wilderotter Mary Agnes Director | Sale 10b5-1 plan | 1,000 | $68.8K |
| Oct 1, 2026 | Shaughnessy James P Chief Legal Officer | Sale 10b5-1 plan | 400 | $27.8K |
| Oct 1, 2026 | Hansen Paula Chief Revenue Officer | Sale 10b5-1 plan | 3,000 | $206.3K |
| Oct 1, 2026 | Hansen Paula Chief Revenue Officer | Sale 10b5-1 plan | 300 | $20.8K |
| Sep 17, 2026 | Chatwani Robert President General Mgr, Growth | Sale 10b5-1 plan | 4,044 | $278.1K |
| Sep 17, 2026 | Chatwani Robert President General Mgr, Growth | Sale 10b5-1 plan | 10,632 | $740.6K |
| Sep 16, 2026 | Wilderotter Mary Agnes Director | Sale 10b5-1 plan | 1,096 | $77.4K |
| Sep 15, 2026 | Shaughnessy James P Chief Legal Officer | Tax withheld | 8,501 | $0 |
| Sep 15, 2026 | Shaughnessy James P Chief Legal Officer | Option exercise | 18,277 | $0 |
| Sep 15, 2026 | Thygesen Allan C. President and CEO | Tax withheld | 33,454 | $0 |
| Sep 15, 2026 | GRAYSON BLAKE JEFFREY Chief Financial Officer | Tax withheld | 17,730 | $0 |
| Sep 15, 2026 | Hansen Paula Chief Revenue Officer | Tax withheld | 19,559 | $0 |
| Sep 15, 2026 | Thygesen Allan C. President and CEO | Option exercise | 67,467 | $0 |
| Sep 15, 2026 | Hansen Paula Chief Revenue Officer | Option exercise | 39,444 | $0 |
| Sep 15, 2026 | Chatwani Robert President General Mgr, Growth | Option exercise | 35,307 | $0 |
| Sep 15, 2026 | Chatwani Robert President General Mgr, Growth | Tax withheld | 17,508 | $0 |
| Sep 15, 2026 | GRAYSON BLAKE JEFFREY Chief Financial Officer | Option exercise | 44,234 | $0 |
| Sep 14, 2026 | Marrs Anna Director | Sale 10b5-1 plan | 548 | $36.7K |
| Sep 10, 2026 | Briggs Teresa Director | Sale 10b5-1 plan | 548 | $35.4K |
| Sep 10, 2026 | Solvik Peter Director | Sale | 30,000 | $1.96M |
| Sep 10, 2026 | Solvik Peter Director | Sale | 16,000 | $1.04M |
| Sep 8, 2026 | GRAYSON BLAKE JEFFREY Chief Financial Officer | Sale 10b5-1 plan | 3,450 | $229.9K |
| Sep 8, 2026 | GRAYSON BLAKE JEFFREY Chief Financial Officer | Sale 10b5-1 plan | 11,550 | $753.6K |
| Sep 5, 2026 | Roberts Brian Keith Director | Option exercise | 856 | $0 |
| Sep 4, 2026 | GRAYSON BLAKE JEFFREY Chief Financial Officer | Sale 10b5-1 plan | 30,000 | $2.10M |
| Sep 3, 2026 | Rosenbaum Michael George Director | Option exercise | 522 | $0 |
| Sep 1, 2026 | Briggs Teresa Director | Option exercise | 1,096 | $0 |
| Sep 1, 2026 | Solvik Peter Director | Option exercise | 1,096 | $0 |
| Sep 1, 2026 | BEER JAMES A Director | Option exercise | 1,096 | $0 |
| Sep 1, 2026 | Salem Enrique T Director | Option exercise | 1,096 | $0 |
| Sep 1, 2026 | Irving Blake Director | Option exercise | 1,096 | $0 |
| Sep 1, 2026 | Wilderotter Mary Agnes Director | Option exercise | 1,096 | $0 |
| Sep 1, 2026 | Hayes Cain A Director | Option exercise | 1,096 | $0 |
| Sep 1, 2026 | Marrs Anna Director | Option exercise | 1,096 | $0 |
| Aug 28, 2026 | BEER JAMES A Director | Sale 10b5-1 plan | 450 | $28.8K |
| Aug 7, 2026 | GRAYSON BLAKE JEFFREY Chief Financial Officer | Sale 10b5-1 plan | 15,000 | $900.0K |
| Aug 2, 2026 | Trollope Rowan M Director | Option exercise | 869 | $0 |
| Jul 1, 2026 | Shaughnessy James P Chief Legal Officer | Sale 10b5-1 plan | 11,754 | $535.2K |
| Jul 1, 2026 | Hansen Paula Chief Revenue Officer | Sale 10b5-1 plan | 6,000 | $273.2K |
| Jul 1, 2026 | Shaughnessy James P Chief Legal Officer | Sale 10b5-1 plan | 246 | $11.3K |
| Jul 1, 2026 | GRAYSON BLAKE JEFFREY Chief Financial Officer | Sale 10b5-1 plan | 600 | $27.6K |
| Jul 1, 2026 | GRAYSON BLAKE JEFFREY Chief Financial Officer | Sale 10b5-1 plan | 14,400 | $655.6K |
| Jul 1, 2026 | Thygesen Allan C. President and CEO | Sale 10b5-1 plan | 21,993 | $1.01M |
| Jul 1, 2026 | Thygesen Allan C. President and CEO | Sale 10b5-1 plan | 4,257 | $194.0K |
| Jun 22, 2026 | Chatwani Robert President General Mgr, Growth | Sale 10b5-1 plan | 6,680 | $290.7K |
| Jun 22, 2026 | Chatwani Robert President General Mgr, Growth | Sale 10b5-1 plan | 9,222 | $393.2K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow DOCUSIGN, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading